New clinical study on Neoss short implants for long-term success
A new clinical study on 7 mm Neoss ProActive® implants has been published by Dr. Paul Rosen and coworkers. This retrospective study followed 86 consecutively placed implants in 75 patients for up to 7 years. Results showed an excellent cumulative survival rate (CSR) of 97.7% after 5 years. Results also demonstrated that high primary stabilities were achieved at insertion and maintained during the healing period. The study concluded that treatment with short implants can be a predictable treatment option with high survival rate in sites with limited available bone.
While there have been a number of prior studies on short dental implants <8mm, the lead author of the paper, Dr. Paul Rosen, feels that this particular study has special significance.
Dr. Rosen comments: “These were patients consecutively treated from my private practice rather than at an academic institution where inclusion and exclusionary criteria would probably be applied. Hence, the cohort reflects the “real world” situations that I face on a daily basis. Another aspect to this retrospective is that the scenarios included these 7 mm length implants being splinted to natural teeth as a fixed partial denture, serving as attachments to removable prosthesis, being abutments in conventional fixed partial dentures, and serving as the foundation for single crowns in both the anterior and posterior of the mouth. The uniqueness of the Neoss 7 mm implant is its versatility, as it comes in 0.5mm width increments, beginning at 3.5 mm and ranging up to 6.0 mm."
The full paper can be read and downloaded HERE.